With the rapid expansion of imaging technologies, molecular markers, and onco-pathological tests, clinicians increasingly face uncertainty about selecting the most appropriate investigations for diagnosing and staging cancer.
Bezorgen: Zodra beschikbaar
With the rapid expansion of imaging technologies, molecular markers, and onco-pathological tests, clinicians increasingly face uncertainty about selecting the most appropriate investigations for diagnosing and staging cancer.